top of page
MEARY
Cell and Gene Therapy Manufacturing
Heads:
Dr. Jean-Roch Fabreguettes
Objectives
Development of experimental ATMPs for early phase clinical trials. Derisking at early stages of product development.
Operator (s)
Technology and expertises
Quality assurance, GMP manufacturing and quality control of ATMPs.
R&D&I in bioproduction (miniaturization, automation).
Development and technology transfer.
Facilities and activities
A modular 800 sqm GMP-grade facility with bioproduction/manufacturing capabilities and a quality control laboratory.
Industrialization of GMP bioproduction processes.
Optimization of mid-scale GMP production processes.
Production of clinical-grade batches of experimental ATMPs for early-phase clinical studies (PoC, Phase I–II).
Expertise in quality management and regulatory affairs.
The MEARY Center for Cell and Gene Therapy is a leading facility in the manufacturing of Experimental Advanced Therapy Medicinal Products (ATMPs), offering cutting-edge expertise to clinicians, research teams and industrial partners to support and conduct cell, tissue and gene therapy clinical trials.
bottom of page